Physician profile
Christine Johnson
NPI 1750661112
$1,669.74
in general payments reported to CMS, 2019-2025
15 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,442 · 2022: $44.09 · 2023: $20.91 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $505.29 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $205.89 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $184.73 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $177.55 | 2021 | |
| Sunovion Pharmaceuticals INC. | $94.96 | 2021 | |
| Lundbeck LLC | $92.90 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.09 | 2021 | |
| Noven Therapeutics, LLC | $63.06 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $56.99 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $53.54 | 2021 | |
| Almatica Pharma LLC | $52.61 | 2021-2025 | Loreev Xr |
| Alkermes, INC. | $24.99 | 2021 | |
| Abbott Laboratories | $24.01 | 2021 | |
| Pajunk Medical Systems, LP | $20.91 | 2023 | E-Cath Plus Acc. Tsui |
| Eisai INC. | $20.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.